| | Class 2 Device Recall Optical Biopsy and Grasping Forceps |  |
| Date Initiated by Firm | December 19, 2024 |
| Date Posted | January 10, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0837-2025 |
| Recall Event ID |
95954 |
| Product Classification |
Instrument, ent manual surgical - Product Code LRC
|
| Product | Karl Storz - Endoskope - REF 723400 - Optical Biopsy and Grasping Forceps, CE |
| Code Information |
Lot Numbers: All lots of the affected material number/Primary DI Number: 04048551194416 |
| FEI Number |
3007475226
|
Recalling Firm/ Manufacturer |
Karl Storz Endoscopy 2151 E Grand Ave El Segundo CA 90245-5017
|
| For Additional Information Contact | Mrs. Kathy Strange 774-284-1736 |
Manufacturer Reason for Recall | Due to failure of manual cleaning validation, biopsy and grasping forceps like sterility assurance. |
FDA Determined Cause 2 | Reprocessing Controls |
| Action | On December 19, 2024, Karl Storz issued a "Urgent: Medical Device Recall" Notification to affected consignees. In addition to informing consignees about the recall, Karl Storz ask consignees to take the following actions:
1. Immediately quarantine and discontinue use of associated part numbers listed.
2. Pass on this Urgent Medical Device Recall Notice to all users of the recalled product and all other persons who need to be aware within your organization.
3. If you have further distributed the recall product, please identify and promptly notify those recipients by providing a copy of the recall notification and response form, or provide KARL STORZ a list of customers who received/may have received the product listed.
4. Return the completed Customer Reply Form by Fax or E-Mail to the indicated contact below within 15 calendar days from the date of receipt.
5. Contact your KARL STORZ representative or call KARL STORZ Customer Support to return affected product.
" Call Customer Support at 800-421-0837 Option 1 to set up an RMA.
" Or call your KARL STORZ representative to assist with setting up an RMA.
6. Please report any incidents related to this issue to the manufacturer, dealer, or local representative and, if applicable, to the national competent authority, as this is important feedback.
7. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
|
| Quantity in Commerce | 285 units |
| Distribution | US: AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, MT,
NC, NE, NJ, NM, NY, OH, OR, PA, SC, TX, VA
OUS: None |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|